Axon Enterprise, Inc. vs Boeing Company (The) — Stock Comparison
Q·Score Breakdown
6.6
Neutral
Overall
6.2
Neutral
Quality
Health
Growth
Valuation
Sentiment
AXON
90% of 20 covering analysts have a positive rating.
⚠ low return on equity (4%).
BA
78% of 27 covering analysts have a positive rating.
⚠ high leverage at 8.3× debt-to-equity.
Analyst Consensus
BUY
Target $707.96 (+76.0%)
18 analysts
BUY
Target $269.52 (+18.5%)
25 analysts
Fundamentals
AXON
BA
262.9×
Trailing P/E
90.2×
38.2×
Forward P/E
53.0×
4.5%
Profit Margin
2.5%
59.8%
Gross Margin
4.8%
4.5%
ROE
169.9%
38.5%
Revenue Growth
14.0%
-98.0%
Earnings Growth
—
1.60
Beta
1.13
—
Price / Book
—
$32.4B
Market Cap
$179.2B
$339 – $886
52-Week Range
$177 – $254
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →